KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Progyny (PGNY) Short-term Investments (2020 - 2025)

Historic Short-term Investments for Progyny (PGNY) over the last 6 years, with Q3 2025 value amounting to $211.2 million.

  • Progyny's Short-term Investments rose 4644.0% to $211.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $211.2 million, marking a year-over-year increase of 4644.0%. This contributed to the annual value of $65.6 million for FY2024, which is 7602.55% down from last year.
  • Per Progyny's latest filing, its Short-term Investments stood at $211.2 million for Q3 2025, which was up 4644.0% from $172.6 million recorded in Q2 2025.
  • In the past 5 years, Progyny's Short-term Investments ranged from a high of $273.8 million in Q4 2023 and a low of $22.1 million during Q3 2021
  • Moreover, its 5-year median value for Short-term Investments was $77.1 million (2021), whereas its average is $117.1 million.
  • Within the past 5 years, the most significant YoY rise in Progyny's Short-term Investments was 38863.78% (2024), while the steepest drop was 7602.55% (2024).
  • Over the past 5 years, Progyny's Short-term Investments (Quarter) stood at $28.0 million in 2021, then surged by 147.18% to $69.2 million in 2022, then surged by 295.53% to $273.8 million in 2023, then crashed by 76.03% to $65.6 million in 2024, then skyrocketed by 221.79% to $211.2 million in 2025.
  • Its Short-term Investments was $211.2 million in Q3 2025, compared to $172.6 million in Q2 2025 and $146.9 million in Q1 2025.